Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II…

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2025

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 21 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 6,449 followers.

RT @VCCLibrary: Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair defici…

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic #colorectalcancer: final survival analysis of the phase II GERCOR NIPICOL study https://t.co/DkSyKPv87Z

RT @GI_Onc_PubMed: #J_Immunother_Cancer IF:10.3 Phase II trial (n=57). Nivolumab-ipilimumab for MSI/dMMR metastatic CRC showed 5-year OS 73…

$lptx cc @deonsi https://t.co/OHxErkD7pw https://t.co/LNZNJy2pZu

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.